Development
ICH Process Q8, Q9, Q10
WHO Workshop, October 2007
ICH Process
ICH Q8, Q9, Q10
Pharmaceutical Development
FUTURE OF ICH
A Continuation of Harmonization
– Activity/Mechanism to harmonize new technical requirements
– Process for updating and supplementing the current ICH
Guidelines
– Prevent future disharmony through early collaboration and
exchange of information
“risk-based”
concepts and
principles of ICH
Q8
Ref: ICH
Q9 Q10
Training Workshop on Pharmaceutical
8 | Development
Pharmaceutical Development Paths
Q8 is not yet finalized by ICH
Q8
Traditional
pharmaceutical
development
QbD
Essential DOE DOE FME(C)A
DOE Factorial design Multivariate analysis
Traditional
Process Validation
Establish documented evidence which will provide a high
degree of assurance that a specific process will
consistently produce a product meeting its predetermined
specification”
Traditional
Process Validation (cont’d)
Process Validation Protocol
Three lots
Extensive and frequent sampling
More than routine testing
Proven homogeneity within a lot
Consistent product quality between three lots
Control
Design Space
Space
Continuous improvement
without regulatory
Design Space
approval
Knowledge Space
ICH - Q9
Risk C&E ICH - Q6
Assessment CPP Specification
Investigation
Process Mapping
Future
Offline Control (quality by design)
– Statistics and process engineering application at design phase
of the product
Ref: ICH
Training Workshop on Pharmaceutical
30 Development
Quality Risk Management
Traditional (basic)
pharmaceutical Enhanced (QbD)
In-depth understanding of process
development